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Abstract
Background: Topors is a nuclear protein that co-localizes with promyelocytic leukemia bodies and has both ubiquitin 
and SUMO E3 ligase activity. Expression studies implicated Topors as a tumor suppressor in various malignancies. To 
gain insight into the function of Topors, we generated a Topors-deficient mouse strain.
Results: Mice homozygous for a mutant Topors allele exhibited a high rate of perinatal mortality and decreased 
lifespan. In addition, heterozygotes were found to have an increased incidence of malignancy, involving a variety of 
tissues. Consistent with this finding, primary embryonic fibroblasts lacking Topors exhibited an increased rate of 
malignant transformation, associated with aneuploidy and defective chromosomal segregation. While loss of Topors 
did not alter sensitivity to DNA-damaging or microtubule-targeting agents, cells lacking Topors exhibited altered 
pericentric heterochromatin, manifested by mislocalization of HP1α and an increase in transcription from pericentric 
major satellite DNA. Topors-deficient cells exhibited a transcriptional profile similar to that of cells treated with histone 
deacetylase inhibitors, and were resistant to the anti-proliferative effects of the histone deacetylase inhibitor 
trichostatin A.
Conclusion: These results indicate a unique role for Topors in the maintenance of genomic stability and pericentric 
heterochromatin, as well as in cellular sensitivity to histone deacetylase inhibitors.
Background
Topors is nuclear protein that is widely expressed in
human tissues [1], and is the first example of protein that
is capable of functioning as both a ubiquitin and SUMO
E3 ligase [2-4]. Furthermore, expression analyses and
genetic studies have implicated TOPORS as a tumor sup-
pressor in colon, lung, brain, and prostate malignancies
[5,1,6].
In proliferating cells, Topors localizes in nuclear foci,
many of which co-localize with PML nuclear bodies [7].
While identified originally as a topoisomerase I- and p53-
binding protein, human Topors and a Drosophila
ortholog were shown to function as RING-dependent E3
ubiquitin ligases, with substrates including p53, the Hairy
transcription factor, and the homeodomain protein
NKX3.1 [2,8,9]. Additional studies indicated that Topors
could act as an E3 SUMO ligase for p53 and topoi-
somerase I, with the RING domain dispensable for this
f u n c t i o n  [ 3 , 4 ] .  F u r t h e r m o r e ,  a  r e c e n t  p r o t e o m i c  s t u d y
identified several proteins involved in chromatin regula-
tion, including Sin3A, as potential sumoylation substrates
for Topors [10]. While a Drosophila ortholog was shown
to be required for proper functioning of a chromatin
insulator [11], physiologically relevant ubiquitination/
sumoylation substrates and the biological role of Topors
remain poorly understood.
To gain insight into the function of Topors, we gener-
ated a Topors-deficient mouse strain using a gene-
trapped allele. Although mice homozygous for the
mutant allele frequently died during the perinatal period,
heterozygous mice appeared normal but had an increased
rate of malignancy.
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Results
Targeted disruption of Topors in mice
Topors-deficient mice were created from a gene-trapped
embryonic stem cell line. The mutant cell line expresses a
fusion transcript including exons 1 and 2 of Topors, with
exon 3 replaced by vector-derived β-galactosidase
sequence (Figure 1). Since exon 3 contains most of the
Topors coding sequence (residues 69-1033), including the
highly-conserved RING domain (residues 103-141)
required for ubiquitination activity [2], and the 437-555
region involved in sumoylation activity [3,4], the protein
derived from the fusion transcript is expected to lack
both the ubiquitin and SUMO ligase activities attributed
to Topors.
Mice heterozygous for the mutant allele appeared phe-
notypically normal and were interbred to obtain homozy-
gotes. Analyses of Topors mRNA expression as a function
of genotype indicated that similar to human tissues [1],
Topors transcription was detectable in several tissues
from Topors+/+ mice, including brain, colon, kidney, and
liver (data not shown). Transcripts containing exon 3
were undetectable in colon tissue obtained from mice
homozygous for the mutant allele, whereas these tran-
scripts were readily detected in colon tissue from
Topors+/+  and  Topors+/-  mice (Figure 1C). Similarly,
immunoblotting with a polyclonal antibody developed
against the human protein [7] confirmed loss of Topors
protein expression in homozygote colon tissues (Figure
1C).
Genotyping of multiple heterozygote intercrosses indi-
cated that Topors-/- mice were present from day E13.5 to
birth at the expected Mendelian ratio (Table 1). However,
Topors-/- mice frequently died during the perinatal period
and those that survived weaning were smaller than their
littermates. Mean adult male weights were 60 ± 7.3 g (n =
6), 46 ± 5.8 g (n = 6), and 32.5 ± 6.5 g (n = 4) for Topors+/+,
Topors+/-, and Topors-/- mice, respectively (p = 0.0003,
Figure 1 Insertional mutation of murine Topors. A. Schematic of the gene-trap insertion into intron 2 of Topors. The three Topors exons are shown 
as rectangles. In exon 3 R represents the conserved RING domain required for ubiquitination activity, and S represents the region involved in sumoy-
lation activity. The SA (splice acceptor), β-geo (β-galactosidase-neomycin) fusion gene, and pA (polyadenylation) sequences present in the gene-trap 
vector are shown. Locations of PCR primers used for genotyping are indicated by arrows. B. Representative PCR-based genotyping of mice obtained 
from breeding heterozygotes. C. Analysis of Topors mRNA and protein expression in colon tissue obtained from Topors+/+, Topors+/-, and Topors-/- mice. 
As indicated in the Methods, RNA expression was evaluated by RT-PCR using primers spanning exons 2-3 and primers within exon 3 only. Actin RNA 
expression was determined using β-actin-specific primers. Protein expression was evaluated by immunoblotting nuclear lysates with a polyclonal an-
tibody generated against the human protein, as well as a β-actin antibody. D. Kaplan-Meier survival analysis of Topors+/+ (n = 40), Topors+/- (n = 69), 
and Topors-/- (n = 7) mice that survived weaning. The insert shows spinal kyphosis in a Topors-/- mouse that was sacrificed at 68 weeks of age.Marshall et al. BMC Molecular Biology 2010, 11:31
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Topors-/- mice compared to Topors+/+ mice, and p = 0.009,
Topors-/- mice compared to Topors+/- mice).
In addition, Topors-/- mice that survived weaning exhib-
ited a high rate of mortality. Predicted median survival
for  Topors-/- mice that survived weaning was 48 weeks
compared to 82 weeks for wild-type littermates (p <
0.0001, logrank test, Figure 1D). Necropsies of Topors-/-
mice did not disclose gross organ abnormalities or other
obvious causes of death. However, spinal kyphosis was
noted in two of seven Topors-/- mice that survived wean-
ing (these mice died at 56 and 68 weeks of age, respec-
tively, Figure 1E). This abnormality was not detected
among wild-type littermates. Both male and female
Topors-/- mice were fertile, indicating that Topors  is not
required for production of functional ova and sperm.
Increased incidence of tumors in mice containing a mutant 
Topors allele
Cohorts of Topors+/+, Topors+/-, and Topors-/- mice were
monitored for several months to investigate the incidence
of tumor formation. In addition, necropsies were per-
formed on all mice in these cohorts that died, to deter-
mine whether malignancy was present. A single tumor
(papillary adenoma of the Harderian gland) was detected
among 40 Topors+/+ mice (2.5% incidence). By contrast,
among 69 Topors+/- mice, 12 tumors (17% incidence) of
various histologies were identified in typically older mice,
and occurred in both males and females (Table 2, Figure
2). Compared to Topors+/+ mice, Topors+/- mice had a 7-
fold increase in risk of tumor development (95% confi-
dence interval 0.94-51.5, p = 0.0167, Fisher's Exact Test).
This finding indicates that haploinsufficiency of Topors is
associated with an increased rate of malignancy in mice.
A small hepatoma was found in a Topors-/- mouse that
died at 48 weeks of age. No malignancies were detected
during necropsy of three other Topors-/- mice that sur-
vived beyond 24 weeks (ages at death were 54, 56, and 68
weeks of age, respectively). Since the median age at which
tumors were detected in Topors+/- mice was 77 weeks, the
high perinatal mortality rate in Topors-/- mice may have
confounded manifestation of an increase in cancer inci-
dence in adult Topors-/- mice.
Topors-deficient primary embryonic fibroblasts exhibit 
slow growth and genetic instability
To investigate the cellular role of Topors, as well as mech-
anisms underlying the increased rate of malignancy
observed in mice with a mutant Topors allele, we analyzed
early passage, Topors-deficient E13.5 primary murine
embryonic fibroblasts (pMEFs). Expression of Topors
RNA and protein was detectable in Topors+/+ pMEFs, but
not in Topors-/- pMEFs (Figure 3A). Early passage Topors-/
- pMEFs exhibited a slower growth rate and reached pla-
teau earlier than wild-type cells (Figure 3B). Calculated
doubling time for the Topors+/+ cells was 1.1 days versus
1.6 days for Topors-/- cells (p = 0.03, F test). Cell cycle
analyses indicated that deficiency of Topors had little
effect on cell cycle distribution (Figure 3C).
To investigate whether loss of Topors was associated
with an increase in the rate of cellular transformation, we
examined the ability of Topors-/- pMEFs to form foci on a
monolayer of cells, and to form colonies in soft agar. In
contrast to wild-type cells, Topors-/- pMEFs frequently
obtained an ability to grow as foci (Figure 4). Similarly,
Figure 2 Representative tumor histologies in Topors+/- mice. Rep-
resentative sections of H&E-stained tissues are shown. A. Papillary 
Harderian gland tumor (×20). B. Thymic lymphoma (×10). C. Histiocytic 
sarcoma involving liver and bladder (x10). D. Bronchoalveolar adeno-
carcinoma of the lung (×10).
Table 1: Genotype Distribution of Mice Generated from Heterozygote Matings.
Genotype P value
Time of genotyping +/+ +/- -/-
Day E13.5 - birth 23 58 19 0.237a
Weaning 16 37 7 0.051a
aChi-square test for a non-Mendelian distributionMarshall et al. BMC Molecular Biology 2010, 11:31
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Topors-/- pMEFs were capable of anchorage-independent
growth in soft agar (Figure 4). These results are consis-
tent with Topors functioning as a tumor suppressor.
Since loss of Topors results in a decrease in cellular pro-
liferation in pMEFs (Figure 3), it is unlikely that Topors
functions as a "gatekeeper"-type tumor suppressor [12].
To investigate whether loss of Topors affected genetic sta-
bility (i.e. whether Topors functions as a "caretaker"-type
tumor suppressor), we analyzed karyotypes in early pas-
sage pMEFs. Among 15 Topors+/+ cell metaphases, 13
(87%) contained the expected diploid number of 40 chro-
mosomes, with one exhibiting tetraploidy, and only two
exhibiting aneuploidy (13% aneuploidy rate, Figure 4). By
contrast, 13 of 23 (56%) metaphases from Topors-/- cells
were neither diploid nor tetraploid, with chromosome
counts ranging from 29 to 79 (Figure 4, p = 0.016 com-
pared to Topors+/+ cells aneuploidy rate, Fisher's Exact
Test). When metaphases from Topors+/- cells were exam-
ined, the aneuploidy rate was found to be similar to that
of Topors+/+ cells, with 3/25 (12%) of metaphases exhibit-
ing aneuploidy (Figure 4).
Since aneuploidy conferred by caretaker-type tumor
suppressors is often related to defects in DNA repair, we
analyzed the sensitivity of Topors-deficient pMEFs to
ionizing radiation and to the DNA-damaging (topoi-
somerase I-targeting) drug topotecan. The results indi-
cated that loss of Topors did not sensitize pMEFs to DNA
damage induced by either ionizing radiation or topotecan
(Figure 5). Similarly, deficiency of Topors did not result in
an increase in DNA double strand breaks in untreated
pMEFs as assessed by analysis of phosphorylated H2AX
(γ H2AX) foci (data not shown). Furthermore, no intra-
chromosomal rearrangements were detected in meta-
phase chromosomes from Topors-/- cells that were ana-
lyzed using spectral karyotyping (Additional File 1: Figure
S1). Together, these results indicate that deficiency of
Topors results in genetic instability manifested by an
increased rate of aneuploidy without an increase in sensi-
tivity to DNA-damaging agents. These results suggest an
underlying defect in chromosomal segregation, but not
DNA repair, in Topors-/- pMEFs.
Next, we investigated dysfunction of the mitotic spindle
and the spindle checkpoint as possible causes of aneu-
ploidy in Topors-deficient cells. Topors+/+ and Topors-/-
pMEFs exhibited similar arrest in the G2/M phase of the
cell cycle after a 12 hour exposure to the microtubule-tar-
geting drug vinblastine (Figure 5). Similar were results
w e r e  o b t a i n e d  a f t e r  a  4 8  h o u r  e x p o s u r e  t o  v i n b l a s t i n e
(data not shown), and deficiency of Topors did not affect
cellular sensitivity to this drug (Figure 5). These results
indicate that the mitotic spindle checkpoint is intact in
Topors-deficient cells. In addition, as assessed by α-tubu-
lin immunoflourescence studies, there was no evidence of
multipolar spindles or abnormal microtubule architec-
ture in Topors-/- pMEFs (data not shown).
Alterations in pericentric heterochromatin and high 
molecular weight SUMO-2/3 conjugates in Topors-deficient 
primary embryonic fibroblasts
Alterations in pericentric chromatin are implicated in
aneuploidy [13], and studies of both human and Droso-
phila Topors orthologs implicate Topors in chromatin
regulation. To investigate centromeric function and peri-
centric heterochromatin in Topors-deficient pMEFs, we
analyzed the localization of heterochromatin protein 1α
(HP1α), which is associated with centromeric regions
during interphase and is required for proper chromo-
somal segregation [14]. As expected in interphase
Topors+/+ pMEFs, HP1α was predominantly localized in
DAPI-rich, pericentric foci (Figure 6). By contrast, in
Table 2: Tumors in Topors+/- mice.
Number Age (weeks) Sex Histology
1434 46 M thymic lymphoma
1445 59 M liver hemangioma
1519 62 M poorly differentiated malignancy of kidney and spleen
1506 64 F splenic lymphoma
1419 75 F papillary Harderian gland tumor
1438 77 F cervical lymph node lymphoma
1421 91 F Histiocytic sarcoma of liver and bladder
1467 92 M lung carcinoma, prostate adenocarcinoma
1426 93 F abdominal lymphocytic lymphoma
1420 106 M bronchioalveolar adenocarcinoma
1418 110 M Histiocytic sarcoma of bladder
1401 117 M bronchial adenomaMarshall et al. BMC Molecular Biology 2010, 11:31
http://www.biomedcentral.com/1471-2199/11/31
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interphase pMEFs lacking Topors, few cells exhibited
pericentric concentration of HP1α, with most cells exhib-
iting a diffuse nuclear localization of the protein (Figure
6A). Loss of Topors did not affect the nuclear content of
HP1α as assessed by immunoblotting (Figure 6B). Since
HP1α is required for cohesin recruitment to centromeres
[15], mislocalization of HP1α provides an explanation for
the aneuploidy observed in Topors-deficient pMEFs.
HP1α localization to pericentric regions has been
shown to require both methylation of lysine 9 on histone
H3, as well as small interfering RNAs originating from
pericentric repetitive DNA [16-18]. Deficiency of Topors
did not affect the pericentric enrichment of trimethylated
H3K9 in interphase cells, or the overall nuclear content of
trimethylated H3K9 as assessed by immunoblotting (Fig-
ure 6). Similarly, no difference was observed in the diffuse
nuclear distribution of H3K9 acetylation in immunofluo-
rescence studies of interphase pMEFs, or in total H3K9
acetylation in Topors-/- versus  Topors+/+ pMEFs (Addi-
tional File 1: Figure S2).
By constrast, studies of RNA transcribed from pericen-
tric (major satellite repeat) DNA in pMEFs demonstrated
Figure 3 Analysis of growth rates and cell cycle distribution in Topors+/+ and Topors-/- pMEFs. A. Expression of Topors RNA and protein in early 
passage pMEFs. Lysates were obtained from pMEF cell lines of the indicated genotype. As indicated, RNA expression was evaluated by RT-PCR, using 
primers spanning Topors exons 2-3, or within exon 3 alone. Actin RNA expression was evaluated using β-actin-specific primers. The right panel shows 
Topors protein expression evaluated by immunoblotting nuclear lysates with a polyclonal antibody generated against the human protein. Tubulin 
immunoblotting is shown as a control for relative protein content. B. Cellular proliferation was assayed in triplicate in Topors+/+ (solid line with circles) 
and Topors-/- (dotted line with squares) early passage pMEFs. C. Representative cell cycle distributions as determined using propidium iodide staining 
and flow cytometry. The table lists mean and standard deviations of cell cycle distribution data obtained from two independent pMEF cell lines. Sta-
tistical analyses indicated no significant differences in mean values of cell cycle phases.Marshall et al. BMC Molecular Biology 2010, 11:31
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increased amounts of these transcripts in Topors-/-
pMEFs compared to Topors+/+ pMEFs (Figure 6C). These
results suggest that the altered HP1α localization in
Topors-deficient pMEFs may relate to an alteration in
pericentric repetitive DNA transcription.
Since Topors is capable of functioning as both a ubiq-
uitin and SUMO E3 ligase, the alterations in HP1α local-
ization and pericentric DNA transcription in Topors-
deficient pMEFs may relate to loss of ubiquitination and/
or sumoylation of a centromeric Topors substrate. While
further work is needed to identify Topors substrates, we
investigated whether deficiency of Topors affected total
levels of ubiquitin, SUMO-1, or SUMO-2/3 conjugates in
pMEFs. No differences in the pattern of ubiquitin or
SUMO-1 conjugates were observed in Topors-/- pMEFs
compared to Topors+/+ pMEFs (Figure 6D). In addition,
the pattern of low molecular weight SUMO-2/3 conju-
gates was similar in Topors-/- and Topors+/+ pMEFs (Figure
6 D ) .  H o w e v e r ,  a  s m a l l ,  b u t  r e p r o d u c i b l e  d e c r e a s e  w a s
suggested in high molecular weight SUMO-2/3 conju-
gates in Topors-/- pMEFs compared to Topors+/+ pMEFs
(Figure 6D). Recently, polymeric conjugation of SUMO-
2/3 was implicated in centromeric function [19,20], rais-
ing the intriguing possibility that the changes in pericen-
tric heterochromatin observed in Topors-deficient cells
may relate to alteration in cellular levels of polymeric
SUMO-2/3 conjugates.
Deficiency of Topors confers a transcriptional state similar 
to exposure to histone deacetylase inhibitors and results in 
resistance to trichostatin A
To gain additional insight into the cellular function of
Topors, we compared gene-expression profiles for
Topors+/+  and  Topors-/-  pMEFs. Using the Affymetrix
Mouse Genome 430 2.0A array, RNA was analyzed from
three independent cultures of each cell type. Selecting a
false discovery rate of 0.0001, 152 probe sets were identi-
fied as differentially expressed in Topors+/+ versus Topors-
/- cells. Among these 152 probe sets, 88 had at least a
mean 3-fold alteration in transcript level, representing 73
genes: 48 upregulated and 25 downregulated in the
Topors-/- MEFs (Additional File 1: Table S1). Topors was
identified as the most highly downregulated transcript in
Topors-/- M E F s  ( A d d i t i o n a l  F i l e  1 :  T a b l e  S 1 ) .  W e  c o n -
firmed differential expression of 11 of the 73 genes using
semi-quantitative RT-PCR (Additional File 1: Figure S3).
Many of the differentially expressed genes are impli-
cated in tumorigenesis, and 5 of the upregulated genes
are involved in the WNT pathway (e.g. Fst, Lgr5, Sfrp1,
Sfrp2, and Wisp2, Additional File 1: T able S1), which is
dysregulated in a variety of cancers [21]. This finding is
similar to a report implicating Topors (TP53BPL) in the
transforming growth factor β signaling pathway [22]. In
addition, among the 73 differentially expressed genes, 57
(40 upregulated, 17 downregulated) had identifiable
Figure 4 Cellular transformation and chromosomal instability in Topors-deficient primary murine embryonic fibroblasts. A. Formation of 
foci by Topors-/- pMEFs after 3 weeks of growth. The upper section shows two representative plates for Topors+/+ and Topors-/- pMEFs. The lower section 
shows 10X-magnified images, including a focus in Topors-/- pMEFs. B. Anchorage-independent growth by Topors-/- pMEFs. 5 × 104 cells were seeded 
in soft agar and colonies assessed after 2 weeks of growth. Shown are two of four colonies detected in Topors-/- pMEF cultures. No colonies were ob-
served in wild-type cultures. C. Distribution of chromosome numbers for metaphases analyzed in two independent Topors+/+ (n = 15), Topors-/- (n = 
23), and Topors+/- (n = 25) early passage pMEF cell lines. Each bar represents a single metaphase. The difference between aneuploidy frequency in 
Topors+/+ versus Topors-/- pMEFs is statistically significant (p = 0.016). D. Representative karyotype of an early passage Topors-/- pMEF cell, showing tri-
somy for chromosome 1.Marshall et al. BMC Molecular Biology 2010, 11:31
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human orthologs that allowed comparison to 453 gene
expression profiles generated by treatment of human cell
lines with 164 different small molecules: the "Connectiv-
ity Map" [23]. The gene expression profile associated with
deficiency of Topors showed strong similarity to the gene
expression profiles associated with three different histone
deacetylase inhibitors: HC toxin, trichostatin A, and vor-
inostat (Figure 7, see Additional File 1: Table S2 for com-
plete results). The similarity of the Topors deficiency
signature to histone deacetylase inhibition is supported
by the occurrence of several replicates with high connec-
tivity scores, and by the finding that structurally distinct
HDAC inhibitors show this similarity (Figure 7). No other
class of compounds was similarly represented among the
gene expression profiles most highly ranked with the
Topors profile (Additional File 1: T able S2). In addition,
w h e n  e v a l u a t i n g  p e r m u t e d  r e s u l t s ,  w h i c h  e s t i m a t e  t h e
enrichment of specific compounds among the most
highly ranked profiles, both vorinostat and trichostatin A
were associated with low permutation p-values (0.0058
and 0.0363, respectively). Together, these findings suggest
that loss of Topors generates a cellular state that is similar
to that created by exposure of cells to histone deacetylase
inhibitors.
To further explore the finding that loss of Topors con-
ferred a cellular state similar to that of histone deacety-
lase inhibition, we investigated the sensitivity of Topors-
deficient pMEFs to the histone deacetylase inhibitor
trichostatin A. The results indicate that loss of Topors
confers a high level of resistance to the anti-proliferative
effects of this compound (Figure 7). This characteristic is
not associated with general resistance to anti-prolifera-
tive drugs, since Topors-/- pMEFs are not resistant to
DNA-damaging agents or to the microtubule-targeting
drug vinblastine (Figure 5).
Discussion
Our studies indicate that mice lacking the dual ubiquitin
and SUMO E3 ligase Topors are viable, but exhibit
increased perinatal mortality and decreased weight, as
well as decreased lifespan. Since there are several ubiq-
uitin and SUMO E3 ligases in mammals [24], it is not sur-
Figure 5 Assessment of the sensitivity of Topors+/+ and Topors-/- pMEFs to DNA-damaging agents and the microtubule-targeting drug vin-
blastine. A-C. Early passage Topors+/+ (solid lines, triangles) and Topors-/- (dotted lines, squares) pMEFs were exposed to increasing doses of ionizing 
radiation or incubated for 72 hours with increasing concentrations of topotecan or vinblastine. Anti-proliferative activity was determined using an MTT 
assay. Data represent means and standard deviations of 3-6 replicates. D. Representative cell cycle distributions observed 12 hours after vinblastine 
exposure, using propidium iodide staining and flow cytometry. The lower panel indicates mean and standard deviations of cell cycle distribution data 
obtained from two independent cell lines. Statistical analyses indicated no significant differences in mean values of cell cycle phases.Marshall et al. BMC Molecular Biology 2010, 11:31
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prising that Topors is dispensable for viability. Our
finding that steady state amounts of total cellular ubiq-
uitin and SUMO-1 conjugates in pMEFs are unaffected
by loss of T opors is also consistent with redundancy of
ubiquitin and SUMO E3 ligases. However, the apparent
decrease in high molecular weight SUMO-2/3 conjugates
in Topors-deficient pMEFs suggests that Topors may
have a non-redundant role in regulation of polymeric
SUMO-2/3 chains. We note that a similar specific role for
Topors in polymeric (as opposed to monomeric) SUMO
conjugation was identified in studies of Topors-induced
sumoylation of topoisomerase I, although these studies
employed SUMO-1 transfections and did not examine
SUMO-2/3 [4].
Similar to our results, an increase in perinatal mortality
as well as decreased weight were reported in mice lacking
Figure 6 Alterations in pericentric heterochromatin and high molecular weight SUMO-2/3 conjugates in Topors-deficient pMEFs. A. Shown 
are representative immunofluorescence images of Topors+/+ and Topors-/- pMEFs using HP1α and trimethyl-H3K9 antibodies. B. Nuclear lysates from 
Topors+/+ and Topors-/- pMEFs were analyzed by immunoblotting with antibodies recognizing histone H3, trimethyl-H3K9, and HP1α as indicated. C. 
Analysis of pericentric major satellite repeat transcription in Topors+/+ and Topors-/- pMEFs. Purified RNA from Topors+/+ and Topors-/- pMEFs was ana-
lyzed using semi-quantitative RT-PCR and primers specific for pericentric major satellite repeat transcripts or GAPDH. For major satellite transcripts, 
results are shown for duplicate assays performed in the presence and absence of reverse transcriptase. The GAPDH assays were performed using a 
10-fold dilution of RNA. D. Analysis of ubiquitin, SUMO-1, and SUMO-2/3 conjugates in Topors+/+ and Topors-/- pMEFs. Whole cell lysates were analyzed 
by immunoblotting with the indicated antibodies. Lanes from left to right for Topors+/+ and Topors-/- pMEFs indicate serial 2-fold dilutions of cellular 
lysates.Marshall et al. BMC Molecular Biology 2010, 11:31
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the SUMO E3 ligase PIAS1 [25], although total SUMO-1
and SUMO-2/3 conjugates were unaffected in thymo-
cytes from PIAS1-deficient mice [25]. A decrease in the
expected number of homozygotes from heterozygote
matings was observed in mice lacking the related SUMO
E3 ligase PIASy, although this was strain dependent, and
mice lacking PIASy were phenotypically normal [26].
Loss of PIASy did not affect total SUMO-1 or SUMO-2/3
c on j u ga t es in MEF s  [26] .  Los s of  t he  S UMO  E3 ligase
RANBP2 results in embryonic lethality [27]. The effect of
RA N B P 2  d e f i c i e n cy  o n  c e l l u l a r  S U M O  c o n j u g a t e s  w a s
not reported in this study [27]. Analogous to mice lacking
PIAS1, there were no gross organ defects in mice
homozygous for the mutant Topors allele, and additional
studies will be necessary to determine the etiology of
both the perinatal mortality as well as the decreased
lifespan observed in Topors-deficient mice.
Our finding that deficiency of Topors results in an
increased rate of malignancy in mice supports previous
analyses implicating TOPORS as a tumor suppressor in
various human malignancies [5,1,6]. Moreover, our stud-
ies of primary embryonic fibroblasts provide the first evi-
dence that loss of Topors confers genetic instability.
Specifically, complete loss of Topors results in a high rate
of aneuploidy, which is due to a defect in mitotic chromo-
s o m e  s e gr e ga t i o n ,  r a t h e r  t h a n  a  d e f ect  i n  D N A  r e pa i r .
Similar to other tumor suppressor genes involved in
chromosome segregation rather than DNA repair, malig-
nancies in Topors-deficient mice occurred predomi-
nantly in older mice, and in a variety of tissues [28].
Notably, the finding that Topors+/- pMEFs did not exhibit
an increased rate of aneuploidy suggests that additional
events, such as alteration of the remaining wild-type
allele, underly the increase in tumorigenesis observed in
Topors+/- mice.
Studies of the mechanisms underlying the chromosome
segregation defect in Topors-deficient pMEFs indicated
that loss of Topors did not affect the mitotic checkpoint,
but resulted in altered pericentric heterochromatin, man-
isfested by mislocalization of pericentic HP1α as well as
increased transcription from pericentric major satellite
repetitive DNA. This finding suggests a role for Topors in
pericentric heterochromatin maintenance, and adds to
several lines of evidence implicating Topors in chromatin
regulation. First, Topors co-localizes with PML nuclear
bodies in human cells [7]. Among other functions, PML
nuclear bodies were shown to contain pericentric satellite
DNA and HP1α, and were specifically implicated in
establishment of pericentric heterochromatin [29]. Simi-
larly, although the human antibody was not able to recog-
nize murine Topors in immunohistochemical studies, cell
fractionation studies of pMEFs indicated that the major-
ity of the Topors protein was present in a fraction con-
taining chromatin and nuclear matrix components ([30],
see Methods).
Second, a Drosophila Topors (dTopors) ortholog inter-
acts with Mod(mdg4)2.2, a member of the gypsy transpo-
son chromatin insulator complex [11]. Chromatin
insulators are DNA sequences defined according to an
ability to both block enhancer-promoter communication,
and to shield genes from silencing conferred by nearby
chromatin modifications such as histone deacetylation
Figure 7 Loss of Topors confers a gene expression profile similar to histone deacetylase inhibition and resistance to trichostatin A. A. From 
a collection of 453 gene expression profiles representing 164 compounds, the expression profiles of the histone deacetylase inhibitors HC toxin, 
trichostatin A, and vorinostat are highly similar to the gene expression profile of murine embryonic fibroblasts lacking Topors. The barview (left) is con-
structed from 453 horizontal lines, each representing an individual treatment instance and ordered by their similarity to the Topors signature. All HC 
toxin (n = 1), trichostatin (n = 12), and vorinostat (n = 2) instances are shown as black lines. Colors applied to the remaining instances reflect positive 
(green), negative (red), or no (gray) similarity to the Topors signature. The table shows the rank, dose, cell line, and connectivity score for each histone 
deacetylase inhibitor treatment instance. B. Topors+/+ (solid lines) and Topors-/- (dotted lines) MEFs were incubated for 72 hours with increasing con-
centrations of trichostatin A. Anti-proliferative activity was determined using an MTT assay. Data represent means and standard deviations of 3-6 rep-
licates. Estimated IC50 values for trichostatin A are 30 ng/ml for Topors+/+ cells versus 232 ng/ml for Topors-/- cells (P < 0.0001, F test).Marshall et al. BMC Molecular Biology 2010, 11:31
http://www.biomedcentral.com/1471-2199/11/31
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[31]. In genetic studies, dTopors  was shown to be
required for gypsy insulator function, and the dTopors
protein was shown to co-localize with nuclear lamin [11].
In mammals, insulators are important in genomic
imprinting, which results in expression of only the mater-
nal or paternal allele [32]. Notably, among the 73 differen-
tially expressed genes identified in our transcriptional
profiling analysis of Topors-deficient pMEFs, 10 were
identified as being imprinted by an expression profiling
screen [33] (Additional File 1: Table S1). Among these,
Xist and Peg3 are well-known imprinted genes [34,35].
Notably, the transcription of other imprinted genes, such
as Igf2 and U2af1-rs1 (probe sets for both are present on
the Affymetrix Mouse Genome 430A 2.0 array) was not
identified as altered in Topors-/- pMEFs, indicating that
loss of T opors does not result in global deregulation of
imprinting.
Third, a search for Topors sumoylation substrates using
a proteomic in vitro screen yielded several chromatin-
related proteins [10]. Among these potential substrates,
KRAB-associated protein 1 (KAP-1)/transcription inter-
mediary factor 1-beta (TIF1-β), histone H4, and Ku70 are
known to interact with HP-1 proteins [14]. In addition,
the p48 subunit of chromatin assembly factor 1 (CAF1)
was identified as a putative Topors substrate [10], with
CAF1 implicated in recruitment of HP-1α to pericentric
heterochromatin [36]. Furthermore, mSin3A was identi-
fied as a potential Topors sumoylation substrate, and
transfection studies indicated that Topors is capable of
sumoylating mSin3A in cells [10]. Since alterations in
mSin3A function lead to chromosomal and genomic
instability and accelerate tumorigenesis [37,38], it is pos-
sible that loss of sumoylation or ubiquitination of mSin3A
or other chromatin proteins by Topors is important in the
altered pericentric heterochromatin observed in Topors-
deficient MEFs.
In this regard, there are several examples of heterochro-
matin and chromosome segregation defects conferred by
alterations in components of ubiquitination or sumoyla-
tion pathways in eukaryotes. Deficiency of the ubiquitin
E3 ligase BRCA1 results in chromosomal instability
[39,40], as well as defects in the chromatin structure of X
chromosomes [41]. BRCA1 localizes in pericentric het-
erochromatin regions in MEFs [42] and was also identi-
fied as a member of a SWI/SNF chromatin remodeling
complex [43]. In addition, a ubiquitin E3 ligase complex
containing cullin 4 was shown to be required for hetero-
chromatin formation and proper chromosomal segrega-
tion in fission yeast [44-46]. Interestingly, this E3 ligase
was also shown to regulate transcription of centromeric
repetitive DNA in yeast [44].
Similarly, deficiency of the SUMO-conjugating enzyme
Hus5/Ubc9 results in abnormal chromosome segregation
in fission yeast [47], and in loss of gene silencing as well as
altered histone modification patterns at heterochromatic
regions [48]. Murine cells lacking the SUMO E2 enzyme
Ubc9 exhibit mitotic chromosome defects, including ana-
phase bridges [49]. Knockdown of the SUMO E3 ligase
PIASγ in human HeLa cancer cells results in a defect in
mitotic chromosome segregation, possibly due to loss of
topoisomerase II sumoylation [50]. Loss of Pli1p, a PIAS
ortholog in fission yeast, also results in chromosomal
instability and reduced transcriptional silencing of cen-
tromeric DNA [51].
Although further studies are needed to determine if the
ubiquitination or sumoylation activities of Topors are
required for maintenance of pericentric heterochromatin,
our finding that loss of Topors may result in a decrease in
polymeric SUMO-2/3 conjugates adds to increasing evi-
dence implicating polymeric SUMO-2/3 chains in cen-
tromere function. For example, polymeric SUMO-2/3
conjugates are implicated in localization of topoi-
somerase IIα to centromeres [52,19], and are required for
localization of CENP-E to kinetochores [20].
Our studies of Topors-deficient cells are also relevant to
the recent discovery of histone deacetylases as therapeu-
tic targets in cancer [53]. Loss of Topors results in resis-
tance to the anti-proliferative effects of histone
deacetylase inhibitors, without affecting cellular sensitiv-
ity to DNA-damaging or microtubule-targeting agents.
Interestingly, aneuploidy, mislocalization of HP1α, as well
as decreased silencing of pericentric DNA [54], occur in
cells treated with histone deacetylase inhibitors [55-57].
Conclusion
Our studies indicate that mice lacking the dual ubiquitin
and SUMO E3 ligase Topors are viable, but exhibit
increased perinatal mortality and decreased weight, as
well as decreased life span. Complete loss of Topors
results in a high rate of aneuploidy in primary embryonic
fibroblasts, which is due to a defect in mitotic chromo-
s o m e  se gr e ga t i o n ,  r a t h e r  t h a n  a  d e f ect  i n  D N A  r e pa i r .
Studies of the mechanisms underlying the chromosome
segregation defect in Topors-deficient pMEFs indicated
that loss of Topors did not affect the mitotic checkpoint,
but resulted in altered pericentric heterochromatin, man-
ifested by mislocalization of pericentic HP1α as well as
increased transcription from pericentric major satellite
repetitive DNA. These results indicate a unique role for
Topors in maintenance of genomic stability and pericen-
tric heterochromatin. Loss of Topors also resulted in
resistance to the anti-proliferative effects of histone
deacetylase inhibitors. Since relatively little is known
regarding mechanisms of resistance to histone deacety-
lase inhibitors, elucidation of the mechanisms by which
loss of Topors confers resistance to these drugs may be
useful in efforts to maximize their effectiveness in the
treatment of patients with cancer.Marshall et al. BMC Molecular Biology 2010, 11:31
http://www.biomedcentral.com/1471-2199/11/31
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Methods
All animal studies were approved by the University of
Medicine and Dentistry of New Jersey Institutional Ani-
mal Care and Usage Committee (IACUC). The IACUC
approval number is I06-046.
Generation and genotyping of Topors-deficient mice and 
embryonic fibroblasts
129/OlaHsd embryonic stem (ES) cells containing a gene-
trapped Topors  allele were obtained from BayGenomics
(DTM034, http://baygenomics.ucsf.edu/). RNA and DNA
sequencing indicated that in these cells, the Topors locus is
interrupted by insertion of the pGT1dTMpfs vector into
Topors intron 2 (http://baygenomics.ucsf.edu and data not
shown). Blastocyst injections were performed with
DTM034 ES cells and a chimeric 129/OlaHsd/C57BL/6J
male was obtained. Germline transmission of the mutant
allele was achieved in a C57BL/6J background, and all mice
described in this study were maintained in a hybrid 129/
OlaHsd and C57BL/6J background. Mice were genotyped
by analyses of DNA obtained from tail clippings, using spe-
cific PCR and primers hybridizing to sequences in Topors
intron 2 and the pGT1dTMpfs vector, as described in
Additional File 1: Methods. Embryonic fibroblasts were
generated from E13.5 embryos using standard methods,
and were grown in DMEM media containing 10% fetal
bovine serum, 1% L-glutamine and 100 U/ml penicillin
and 100 μg/ml streptomycin.
Topors RNA and protein analyses
Topors RNA expression was analyzed in mouse tissues
and primary embryonic fibroblasts by RT-PCR using two
sets of primers: one set with the upstream primer
designed to hybridize to exon 2 and the downstream
primer to exon 3, yielding a 1.2 kb product. For the sec-
ond primer set, both primers were designed to hybridize
to exon 3, yielding a 660 bp product. Primers hybridizing
to β-actin were used as a control. Primer sequences and
details of the RT-PCR conditions are provided in Addi-
tional File 1: Methods.
Topors protein expression was assessed in tissues and
embryonic fibroblasts using a chromatin extraction
method as described previously [30]. Briefly, cells were
resuspended or tissue was homogenized in buffer A (10
mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol, 1 mM dithiothreitol, 0.5 μg/ml leu-
peptin, 1 μg/ml pepstatin, and 1 mM PMSF). Triton X-
100 was added to a final concentration of 0.1%. Following
incubation on ice, the nuclei (fraction P1) were collected
by centrifugation at 1,300 × g. The nuclei were washed
once in buffer A and resuspended in buffer B (3 mM
EDTA, 0.2 mM EGTA, 1 mM DTT with protease inhibi-
tors as described above). Following a 30-minute incuba-
tion on ice, soluble (fraction S2) and insoluble
(chromatin, fraction P2) fractions were separated by cen-
trifugation for 5 minutes at 1,700 × g. The insoluble chro-
matin pellet was further processed by resuspension in a
solution containing 10 mM Tris-Cl, 10 mM KCl, 1 mM
CaCl2, and 1 U micrococcal nuclease (Sigma). After 5
minutes of incubation at 37°C, the reaction was stopped
by addition of 1 mM EGTA. Fractions were analyzed by
boiling for 10 minutes in SDS-sample buffer (60 mM
Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% phenol
red) containing 1 mM DTT, followed by SDS-polyacryl-
amide electrophoresis and immunoblotting using a poly-
clonal antibody generated against human Topors [7], as
well as a tubulin antibody (Sigma). The majority of the
Topors protein in both tissues and embryonic fibroblasts
was present in the chromatin fraction P2.
Embryonic fibroblast growth, cell cycle, and karyotype 
analyses
Growth rates of murine embryonic fibroblasts generated
from E13.5 embryos were determined by seeding 100,000
early passage cells in triplicate. Viable cell counts were
determined each day using an automated cell counter
(Beckman Vi-Cell Coulter Counter). Cell cycle distribu-
tions were determined for exponentially growing cells
using ethanol fixation, propidium iodide staining, and
flow cytometry as described previously [1].
Cellular foci formation was assessed by seeding 106
cells in DMEM media in triplicate. After a period of 3
weeks, cells were fixed in methanol and stained with
Giemsa for manual counting of foci. Anchorage-indepen-
dent growth was evaluated by seeding 5 × 104 cells in
DMEM media containing 0.3% low melting point aga-
rose. After 2 weeks the cells were stained with crystal vio-
let and colonies counted manually.
Metaphase chromosome spreads were obtained by
treating cells with 0.13 μg/ml colcemid for 2 hours to
induce mitotic arrest. Metaphase chromosome spreads
were trypsin-Giemsa banded and karyotypes analyzed as
described previously [58].
Drug and ionizing radiation anti-proliferative assays
Topotecan and vinblastine were obtained from GlaxoS-
mithKline (King of Prussia, PA, USA) and Sigma-Aldrich
Chemical Company (St. Louis MO, USA), respectively.
Stock solutions were maintained as 10 mM concentra-
tions in DMSO. Radiation experiments were performed
using a cesium 137-based cell irradiator (model IBL-
473C, CIS-US, Inc). Anti-proliferative effects of drugs
and ionizing radiation on primary embryonic fibroblasts
were determined using tetrazolium dye-based MTS or
MTT assays as described [59]. Concentrations associated
with 50% inhibition of growth (IC50) were identified using
non-linear (sigmoidal) regression analyses (Prism,
GraphPad Software, Inc.).Marshall et al. BMC Molecular Biology 2010, 11:31
http://www.biomedcentral.com/1471-2199/11/31
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Immunofluorescence and immunoblotting assays
For immunofluouresence studies, exponentially prolifer-
ating cells were grown on cover slips, then fixed in 4%
paraformaldehyde for 10 minutes at room temperature.
After washing and permeabilization with 0.5% Triton X-
100, the cells were incubated for 1 hour at room tempera-
ture with the primary antibody diluted in 5% goat serum.
Primary antibodies were used that recognized H2A.X
phosphorylated on serine 139 (Millipore/Upstate, Bed-
ford, MA), HP-1α, (Millipore/Upstate), trimethyl-histone
H3 (Lys9) (Millipore/Upstate), acetyl-histone H3 (Lys9)
(Abcam, Cambridge, MA) and α-tubulin (Millipore/
Upstate). After washing, the cells were incubated with the
appropriate secondary antibody in 5% goat serum. Cells
were mounted onto slides using DAPI-containing mount-
ing media (Vectashield, Vector Laboratories, Inc., Burl-
ington, CA).
For immunoblotting studies, nuclear and chromatin
proteins were obtained as described above. For analysis of
total cellular ubiquitin, SUMO-1, and SUMO-2/3 conju-
gates, cells were lysed in SDS-sample buffer containing 25
mM N-ethylmaleimide (Sigma). In addition to the anti-
bodies listed for immunofluorescence studies, immunob-
lotting antibodies included total histone H3 (Sigma), α-
tubulin (Sigma), ubiquitin (Santa-Cruz), SUMO-1
(Zymed), and SUMO-2/3 (Zymed).
Pericentric major satellite transcript analyses
These assays were performed in a manner similar to that
described by Lehnertz, et al. [60]. Briefly, total RNA was
extracted using RNeasy (Qiagen), then treated with
TURBO DNase (Ambion). First strand cDNA was syn-
thesized in a 20 μl volume using 1 μg of RNA, 200 U
Superscript II reverse transcriptase (Invitrogen), 0.5 μg/μl
random hexadeoxynucleotide primers (Promega), and 0.5
mM dNTPs. 2 μl of the cDNA product (or a 10-fold dilu-
tion of this product) was used in a PCR reaction





also contained 1.5 mM MgCl2, 50 mM KCl, 20 mM Tris-
HCL (pH 8.4), 0.2 mM dNTPs, and 2 units Taq DNA
polymerase (Invitrogen). Thermocycling parameters for
the PCR reactions were as follows: 95°C for 2 minutes,
followed by 35 cycles of 94°C, 30 seconds/60°C, 45 sec-
onds/72°C, 90 seconds, followed by a final incubation at
72°C for 10 minutes. PCR products were analyzed by
1.5% agarose gel electrophoresis and ethidium bromide
staining.
Gene expression profiling and analyses
Transcriptional profiling was performed utilizing 15 μg
total RNA obtained from 3 independent cultures of
Topors+/+  and  Topors-/-  E13.5 early passage embyronic
fibroblasts. RNA was isolated (RNeasy, Qiagen) and
reverse transcribed using oligo-dT primers. Following
RNase H-mediated second-strand cDNA synthesis, dou-
ble-stranded cDNA was purified and transcribed using
T7 RNA Polymerase and a biotinylated nucleotide ana-
log/ribonucleotide mix (One-Cycle Target Labeling and
Control Reagents, Affymetrix). The resulting biotinylated
cRNA was hybridized to an Affymetrix Mouse Genome
430A 2.0 microarray. Gene expression values were deter-
mined using GCOS software (version 1.4, Affymetrix)
and a global scaling normalization method (target value
150). The data were log-transformed and analyzed using
a modified t-test and a defined false discovery rate as
described by Tusher and Efron [61,62].
The Topors deficiency signature was developed by
selecting genes that were associated with a false discovery
rate of 0.0001, and for which there was at least a 3-fold
mean difference in transcript expression. Among the 73
genes that met these criteria, 57 had identifiable human
orthologs and thus comprised the Topors deficiency sig-
nature. This signature was compared to 453 gene expres-
sion profiles present in the Connectivity Map [23]. For
each of the 453 profiles, a connectivity score was calcu-
lated (based on the Kolmogorov-Smirnov statistic), which
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